1. Home
  2. AOD vs ABCL Comparison

AOD vs ABCL Comparison

Compare AOD & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo abrdn Total Dynamic Dividend Fund of Beneficial Interest

AOD

abrdn Total Dynamic Dividend Fund of Beneficial Interest

HOLD

Current Price

$9.95

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.91

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AOD
ABCL
Founded
2006
2012
Country
United Kingdom
Canada
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
AOD
ABCL
Price
$9.95
$3.91
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$7.75
AVG Volume (30 Days)
423.5K
5.0M
Earning Date
01-01-0001
02-24-2026
Dividend Yield
12.95%
N/A
EPS Growth
213.63
N/A
EPS
1.93
N/A
Revenue
$72,962,082.00
$35,325,000.00
Revenue This Year
N/A
$25.45
Revenue Next Year
N/A
$10.07
P/E Ratio
$4.44
N/A
Revenue Growth
N/A
7.17
52 Week Low
$6.99
$1.89
52 Week High
$9.14
$6.52

Technical Indicators

Market Signals
Indicator
AOD
ABCL
Relative Strength Index (RSI) 52.38 46.75
Support Level $9.92 $3.92
Resistance Level $10.06 $4.25
Average True Range (ATR) 0.11 0.31
MACD -0.01 -0.03
Stochastic Oscillator 39.51 5.50

Price Performance

Historical Comparison
AOD
ABCL

About AOD abrdn Total Dynamic Dividend Fund of Beneficial Interest

Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: